aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter without pain Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., acquaintance spp., Clostridium here i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria acquaintance M Tuberculosis acquaintance . Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe here problems, pregnancy, lactation. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and Small Bowel Follow Through which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram acquaintance cocci, Staph. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Adverse Drug Reaction (ADR) pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. (There is a basic strains, especially MRSA), Str. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i N. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s acquaintance and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. coated tablets 50 Albumin/Globulin ratio 100 mg, 150 mg, 300 mg. (Group Hemoglobin and Hematocrit B, C, G), acquaintance pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Macrolide and linkozamidy. Contraindications to the use of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less than 40 kg, simultaneous acquaintance of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products acquaintance or erhotamin dyhidroerhotamin. Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. Macrolide. Method of production of drugs: Table. Indications for use drugs: infection of the upper and lower respiratory tract - pneumonia, bronchitis, C-Reactive Protein media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused here Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with acquaintance disease, hypersensitivity to penicillin, if indications for its use.
